Moreover, this study demonstrated that KP-54 treatment significantly reduced the invasiveness of bladder cancer cells and lung metastasis in a metastasis animal model by inhibiting the expression and activity of MMP-9 via blockage of the nuclear translocation of NF-kB, a transcriptional regulator of MMP-9. The gene discussed is MMP9; the disease is urinary bladder carcinoma.